Mindfulness meditation reduces anxiety as much as a common antidepressant drug, study finds

Mindfulness meditation reduces anxiety as much as a common antidepressant drug, study finds


Mindfulness meditation is as effective at reducing anxiety as a commonly prescribed antidepressant, according to a study published in a major journal on Wednesday.

The study, led by researchers at Georgetown University Medical Center, is the first randomized clinical trial to compare the effectiveness of mindfulness meditation with the antidepressant escitalopram. The results were published in JAMA Psychiatry, a peer-reviewed journal.

The adult participants in the mindfulness group practiced 45-minute daily meditations using a few different techniques they learned at weekly classes. They also went on daylong weekend retreats.

The meditation techniques included breath awareness; body scanning, in which attention is directed to one body part at a time; and mindful movement, in which stretching and movements bring attention to the body.

Participants in the antidepressant group received 10mg of escitalopram daily the first week, and then took 20mg daily for the rest of the study if the pill was well tolerated. There were 102 patients in the mindfulness group and 106 in the antidepressant group. Escitalopram is sold under the brand names Lexapro and Cipralex, among others.

After monitoring the two groups for eight weeks, researchers found that people using mindfulness meditation saw their anxiety improve nearly as much as people who were taking the antidepressant.

Dr. Elizabeth Hoge, lead author on the study, said the findings support physicians recommending mindfulness meditation as an alternative to antidepressants for some patients. Many people worry that antidepressants will interfere with their daily lives and others start taking medications but stop.

Hoge, who is director of Georgetown University’s Anxiety Disorders Research Program, said the study also provides evidence for insurers to cover mindfulness meditation as a treatment for anxiety.

Anxiety disorders are the most common type of mental illness, affecting about 301 million people around the world, according to a February study published in Lancet Psychiatry.



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More